Bristol Myers Squibb Market Access Strategy Lead (MASL) - Innovative Medicines in Princeton, New Jersey
The Market Access Strategy Lead (MASL) will be responsible for the overall worldwide market access strategy for multiple assets in the Innovative Medicines portfolio (all non-oncology, including several of the 17 assets in development for immunoscience, hepatic and pulmonary fibrosis, cardiovascular). He or she will provide input into the development and commercialization strategy from a market access perspective, and assist the markets through product launch.
The position is cross functional in nature and is part of a highly matrixed organization. The MASL will partner with the commercial, pricing, HEOR, medical, regulatory, clinical, business Insights & analytics, and policy WW leads for Innovative Medicines as well as the relevant individual market stakeholders across the world to optimally and position BMS products for success in an increasingly challenging and evolving access landscape.
The MASL will have relationships and interactions with stakeholders in field based functional market roles, up to senior worldwide management. A motivated, inclusive, and decisive outlook is essential for success.
To develop worldwide market access strategies and access advice for BMS' pipeline of Innovative Medicines and business development opportunities through: evaluating payer insights/perspectives; assessing payer appropriateness of clinical development programs, and recommending modifications to these programs if appropriate; influencing brand strategies based on access and pricing insights; reviewing and leading the approval of new business cases for in-market brands; due diligence on business development opportunities; and leading cross functional teams in a matrixed organization.
Development of strong payer value propositions articulating bold and differentiated messages on clinical, humanistic and economic benefits, and that those propositions are supported by strong evidence coming from registrational trials, non-registrational trials, and real-world data in appropriate timelines for the worldwide brand / indication launch. Working with BMS HEOR and regulatory teams to seek optimal PRO claims in the product label as appropriate, and maximize the economic value of assets.
Monitor competitive environment and update cross functional teams on important access developments.
Strong understanding of the current and evolving global market access environment in Innovative Medicines (At least one of the core areas: Immunoscience, cardiovascular, and fibrosis (proxies as HCV, diabetes, obesity, cardiovascular, pulmonary disease),
Ability to translate scientific/clinical value into economic value
Strong financial acumen, and ability to navigate corporate annual reports and finance documents
Ability to efficiently and accurately articulate access strategy to senior, cross functional, stakeholders with potentially limited understanding of the access environment in a particular disease area
Demonstrated ability to formulate effective market access strategy and lead cross-functional teams
Solid understanding of the biopharmaceuticals industry in Innovative Medicines; familiarity with KOLs and their clinical beliefs in the core disease areas a plus
At least a basic understanding of health economic models and cost effectiveness
Minimum of 8-10 years’ experience with a strong track record in Market Access, Pricing or HEOR in a Global/WW or large country market. Alternatively, significant experience with a highly reputable consultancy in the access space with US, and EU5
Demonstrated ability to establish unmet needs and drive value perception
Knowledge of the product development and commercialization process
Launch / commercialization experience desired
Ability to travel to international congresses and BMS internal meetings
Demonstration of all BMS Behaviors, including Accountability, Innovation, Passion & Speed
Undergraduate degree required, MBA and/or post graduate degree required
Equal Opportunity Employer Minorities/Women/Protected Veterans/Disabled